Literature DB >> 23225385

A marginal level of dystrophin partially ameliorates hindlimb muscle passive mechanical properties in dystrophin-null mice.

Chady H Hakim1, Dongsheng Duan.   

Abstract

INTRODUCTION: The goal of this study was to determine whether a minimal level of dystrophin expression improves the passive mechanical properties of skeletal muscle in the murine Duchenne muscular dystrophy model.
METHODS: We compared the elastic and viscous properties of the extensor digitorum longus muscle (EDL) in mdx3cv and mdx4cv mice at 6, 14, and 20 months of age. Both strains are on the C57Bl/6 background, and both lose the full-length dystrophin protein. Interestingly, mdx3cv mice express a near full-length dystrophin at ≈ 5% of the normal level.
RESULTS: We found that the stress-strain profile and the stress relaxation rate of the EDL in mdx3cv mice were partially preserved in all age groups compared with age-matched mdx4cv mice.
CONCLUSION: Our results suggest that a low level of dystrophin expression may treat muscle stiffness in Duchenne muscular dystrophy.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23225385      PMCID: PMC3531902          DOI: 10.1002/mus.23536

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  13 in total

1.  Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice.

Authors:  V M Chapman; D R Miller; D Armstrong; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

2.  Gender differences in contractile and passive properties of mdx extensor digitorum longus muscle.

Authors:  Chady H Hakim; Dongsheng Duan
Journal:  Muscle Nerve       Date:  2012-02       Impact factor: 3.217

3.  Muscle and joint elastic properties during elbow flexion in Duchenne muscular dystrophy.

Authors:  C Cornu; F Goubel; M Fardeau
Journal:  J Physiol       Date:  2001-06-01       Impact factor: 5.182

4.  Preservation of muscle force in Mdx3cv mice correlates with low-level expression of a near full-length dystrophin protein.

Authors:  Dejia Li; Yongping Yue; Dongsheng Duan
Journal:  Am J Pathol       Date:  2008-04-01       Impact factor: 4.307

5.  Differential expression of dystrophin isoforms in strains of mdx mice with different mutations.

Authors:  W B Im; S F Phelps; E H Copen; E G Adams; J L Slightom; J S Chamberlain
Journal:  Hum Mol Genet       Date:  1996-08       Impact factor: 6.150

6.  New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin.

Authors:  G A Cox; S F Phelps; V M Chapman; J S Chamberlain
Journal:  Nat Genet       Date:  1993-05       Impact factor: 38.330

7.  Stiffness of knee extensors in Duchenne muscular dystrophy.

Authors:  C Cornu; F Goubel; M Fardeau
Journal:  Muscle Nerve       Date:  1998-12       Impact factor: 3.217

8.  Human dystrophin expression corrects the myopathic phenotype in transgenic mdx mice.

Authors:  D J Wells; K E Wells; F S Walsh; K E Davies; G Goldspink; D R Love; P Chan-Thomas; M G Dunckley; T Piper; G Dickson
Journal:  Hum Mol Genet       Date:  1992-04       Impact factor: 6.150

9.  Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin.

Authors:  D E Bulman; E G Murphy; E E Zubrzycka-Gaarn; R G Worton; P N Ray
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

10.  Improved diagnosis of Becker muscular dystrophy by dystrophin testing.

Authors:  E P Hoffman; L M Kunkel; C Angelini; A Clarke; M Johnson; J B Harris
Journal:  Neurology       Date:  1989-08       Impact factor: 9.910

View more
  5 in total

Review 1.  What is the level of dystrophin expression required for effective therapy of Duchenne muscular dystrophy?

Authors:  Dominic J Wells
Journal:  J Muscle Res Cell Motil       Date:  2019-07-09       Impact factor: 2.698

2.  AAV genome loss from dystrophic mouse muscles during AAV-U7 snRNA-mediated exon-skipping therapy.

Authors:  Maëva Le Hir; Aurélie Goyenvalle; Cécile Peccate; Guillaume Précigout; Kay E Davies; Thomas Voit; Luis Garcia; Stéphanie Lorain
Journal:  Mol Ther       Date:  2013-06-11       Impact factor: 11.454

3.  Inhibition of muscle fibrosis results in increases in both utrophin levels and the number of revertant myofibers in Duchenne muscular dystrophy.

Authors:  Oshrat Levi; Olga Genin; Corrado Angelini; Orna Halevy; Mark Pines
Journal:  Oncotarget       Date:  2015-09-15

4.  Loss of niche-satellite cell interactions in syndecan-3 null mice alters muscle progenitor cell homeostasis improving muscle regeneration.

Authors:  Addolorata Pisconti; Glen B Banks; Farshad Babaeijandaghi; Nicole Dalla Betta; Fabio M V Rossi; Jeffrey S Chamberlain; Bradley B Olwin
Journal:  Skelet Muscle       Date:  2016-10-04       Impact factor: 4.912

5.  Multi-slice MRI reveals heterogeneity in disease distribution along the length of muscle in Duchenne muscular dystrophy.

Authors:  Stephen M Chrzanowski; Celine Baligand; Rebecca J Willcocks; Jasjit Deol; Ilona Schmalfuss; Donovan J Lott; Michael J Daniels; Claudia Senesac; Glenn A Walter; Krista Vandenborne
Journal:  Acta Myol       Date:  2017-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.